EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY-NC 4.0

Long-Term Proton Pump Inhibitor Use and Gastric Cancer Risk: Interpreting Population-Based Evidence

Hae Won Yoo iD

Gut and Liver · 15.07.2026 · 20 (4) · 497-498

DOI: 10.5009/gnl260247 ↗

Kurz gefasst

Editorial in der Zeitschrift Gut and Liver, erschienen am 15.07.2026. Verfasst von Hae Won Yoo. Beteiligte Einrichtung: Digestive Disease Center and Research Institute, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University…. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Digestive Disease Center and Research Institute, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea.

ORCID-Profile: Hae Won Yoo

Zitieren

APA

Yoo, H. W. (2026). Long-Term Proton Pump Inhibitor Use and Gastric Cancer Risk: Interpreting Population-Based Evidence. Gut and Liver, 20(4), 497-498. https://doi.org/10.5009/gnl260247

Vancouver

Yoo HW. Long-Term Proton Pump Inhibitor Use and Gastric Cancer Risk: Interpreting Population-Based Evidence. Gut and Liver. 2026;20(4):497-498. doi:10.5009/gnl260247

BibTeX
@article{Yoo2026,
  author = {Yoo, Hae Won},
  title = {Long-Term Proton Pump Inhibitor Use and Gastric Cancer Risk: Interpreting Population-Based Evidence},
  journal = {Gut and Liver},
  year = {2026},
  volume = {20},
  number = {4},
  pages = {497--498},
  doi = {10.5009/gnl260247}
}
Kostenlos starten →